What is the main business of Medtransfer?

The main business activity of Medtransfer focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on February 26, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Na Zjeździe 11, 30-527 Kraków.

Who is on the management board?

The management board consists of: Innocenta Dźwierzyńska (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 40,000 (approx. $10,805).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

How much revenue was generated?

In 2022, the company generated total revenue of $21,666, representing a decrease of 88.1% compared to 2021.

Is the company profitable?

No, in 2022 the company was not profitable, reporting a net loss of $141,261. For comparison, in 2021 the loss was $30,200, meaning the company increased its loss by 439.5%.

Which cost dominates operating expenses?

The largest operating cost category falls under external services. This category amounted to $90,475 in 2022, representing 56% of all operating expenses.

Medtransfersp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-02-26

Share capital

40 000,00 PLN

Activity description

Exadel builds enterprise software and helps companies modernize legacy systems. The company also works on responsible AI adoption, data engineering and analytics, and digital experiences from mobile to enterprise applications. It provides program delivery and modernization leadership for complex transformation projects.

Registered address

ul. Na Zjeździe 11, 30-527 Kraków, Poland

Website

codete.com

Social media

Financials

The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue

This companyUSD 21.67kMedianUSD 38.31kAverageUSD 2.31m

Net profit

This companyUSD -141.26kMedianUSD -1.50kAverageUSD -84.98k

Operating costs

This companyUSD 161.87kMedianUSD 56.25kAverageUSD 2.29m

Assets

This companyUSD 3.15kMedianUSD 116.77kAverageUSD 2.72m

Industry

Bank accounts

Was a VAT taxpayer from 2021-03-10 to 2023-06-13. Removed from VAT register

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

1 closed proceeding recorded in KRZ history. Closed proceedings in history

Registration date	Proceeding type	Status
Apr 4, 2023	Petition to declare entrepreneur bankruptcy	Closed

MSiG notices

Publication date	Event
Aug 1, 2025	Dissolution without liquidation opened

Public aid

Grant date	Purpose	Gross amount	Granting body
May 7, 2021	Aid for SME access to finance — aid for start-ups	$207.0K$206,991	Dyrektor Narodowego Centrum Badań i Rozwoju

Tenders

No recorded participation in tenders.

Authorized Representatives

Innocenta Dźwierzyńska — President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Innocenta Dźwierzyńska (46)	95	$1,283.09	11.875%
Kvarko sp. z o.o.	96	$1,296.60	12%
Karol Grzegorz Przystalski (43)	438	$5,915.72	54.75%
Westa Investments S.A.	96	$1,296.60	12%
Others	75	$1,012.97	9.375%

Beneficial owners

Person	Rights
Karol Przystalski (43)	Shareholder of a limited liability company, 21900.0 PLN

Competitors

	Name	Revenue	Website
	AI4Isp. z o.o.	$8,770.79	ai4i.pl

Change history

Date	Event
2021-07-14	Share capital change (5,000.00 PLN → 40,000.00 PLN)
2021-07-14	PKD change (Removed: 62.01, 62.09, 85.59.B; Added: 18.20.Z, 58.21.Z, 58.29.Z, 62.01.Z, 72.11.Z, 72.19.Z, 73.11.Z, 74.90.Z)
2021-02-26	Entered in the register

FAQ

Last updated: 2026-04-24